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1. Introduction 
Fluorescein isothiocyanate, generally used as a non- 
specific fluorescent probe for labeling of proteins, was 
demonstrated to be an efficient inhibitor of the Na’, 
K’-ATPase [l] and of the Ca2+-ATPase from sarco- 
plasmic reticulum [2]. Incubation of the Ca”-ATPase 
from sarcoplasmic reticulum with PM levels of FITC 
at alkaline pH led to complete inhibition of the activ- 
ity within a few minutes. Binding of 1 fluorescein 
molecule/2 Ca’+-ATPase polypeptides (M, 105 000) 
resulted in complete inhibition of the activity which 
may suggest hat the active form of the enzyme is at 
least a dimer. ATP effectively protected against FITC 
inhibition both the Na+, K’-ATPase and the Ca2+- 
ATPase [ 1,2]. 
Taken together these results may suggest hat FITC 
is a selective affinity probe for the ATP binding site 
probably labeling a lysine group at or close to the 
ATP binding site in both ATPases. 
Here, we demonstrate that FITC specifically blocks 
the ATP binding site of the Ca2+-ATPase from sarco- 
plasmic reticulum and does not prevent the phospho- 
rylation of the enzyme by Pi or Ca2+-uptake with ace- 
tyl phosphate as a substrate. The implications of these 
findings for the role of the regulatory ATP binding 
site are discussed. The usefulness of this probe to fol- 
low interconversions between phosphorylated and 
non-phosphorylated conformational states of the 
Ca2*-ATPase is described in [3]. 
2. Materials and methods 
Fragmented SRV were prepared from rabbits as in 
Abbreviations: SRV, sarcoplasmic reticulum vesicles; FITC, 
fluorescein isothiocyanate; AMP-P(NH)P, adenylyl imidodi- 
phosphate 
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[4]. Incubation of SRV with FITC was done at 20°C 
by suspending 150-225 pg SRV protein in 100 ~1 
containing: 0.25 M sucrose, 25 mM Tris-HCl, 25 mM 
Na-glycine at the indicated pH and 100 PM EGTA. 
FITC was added from a freshly made dimethyl form- 
amide solution. The incubation was terminated after 
10 min either by addition of 400 ~1 ice-cold solution 
containing: 0.2 M sucrose, 50 mM Tris-HCl (pH 7 .O) 
and 5 mM Na-ATP (stopping solution) or by transfer- 
ing 100 ~1 samples through a Sephadex G-50 column 
(in 1 ml tuberculin syringe) preequilibrated with ice- 
cold stopping solution, not containing ATP, as in [5]. 
The activities were measured within 30 min. Ca2+-up- 
take was measured by the Dowex procedure [6]. Phos- 
phorylation by [T-~~P]ATP [7] and by Pi [8] were 
measured as described. FITC (isomer I), nucleotides 
and other chemicals were obtained from Sigma. 
3. Results 
In [2] we have reported that FITC is an extremely 
potent inhibitor of the Ca2+-ATPase from sarcoplas- 
mic reticulum. We have demonstrated that following 
incubation at alkaline pH with FITC, one fluorescein 
equivalent bound per two equivalents of 105 000 M, 
polypeptides resulted in a complete inhibition of the 
Ca2’-ATPase and Ca’+-uptake activities. 
The presence of ATP in the incubation mixture 
protected against the inhibition by FITC and pre- 
vented the binding to the enzyme which may suggest 
competition for a common binding site. An apparent 
competition between FITC and ATP is indeed demon- 
strated in fig.1. At higher FITC concentrations a 
higher ATP concentration was required for effective 
protection. Even though the kinetic interpretation of 
these data is not straight-forward because FITC is an 
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F&l. Competition between ATP and FITC. SRV were incu- 
bated 10 mm at pH 8 .O with ATP and FITC at the indicated 
concentrations and assayed for Ca’+-uptake as in section 2. 
The control rate was 1240 nmol Ca’+ . mg protein-’ . min-‘. 
irreversible inhibitor it is quite evident that a 5-fold 
increase of the inhibitor concentration requires 
-5-fold higher ATP concentrations for effective pro- 
tection It should be noted that the incubations with 
FITC were done at pH 8 .O and not at pH 10 which is 
optimal for FITC inhibition in order to test the inter- 
action of the enzyme with ATP under more physio- 
logical conditions. 
Fig2 shows that protection against FITC is very 
specific for adenine nucleotides and does not involve 
phosphorylation of the enzyme since both ADP (in 
the presence of glucose and hexokinase) and the non- 
hydrolyzable ATP analog AMP P(NH)P effectively 
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Fig.2. Protection against FITC is specific to adenine nucle- 
otides. SRV were incubated 20 mm at pH 8.0 with 30 nM 
FITC and the additions indicated in the figure and assayed 
for Ca*+-uptake. The control rate was 1275 nmol Ca’+ . mg 
protein-’ . mm-‘. 
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Fig.3. The effect of FITC on phosphoprotein formation from 
[“P]ATP and 3*Pi SRV (2.2 mg/ml) was incubated 10 min at 
pH 10 with FITC at the indicated concentrations. The incu- 
bation was terminated by transferring samples through 
Sephadex G-SO columns to remove the unreacted reagent. 
Samples containing 330 gg protein were taken for the phos- 
phorylation assays. The control extent of 32Pi ncorporation 
were 3.4 nmoijmg protein and 2.9 nmoljmg protein with 
[r-‘*P]ATP and “Pi, respectively. Other conditions were as 
in section 2. 
protected the enzyme. Adenine monophosphate and 
3’,S’cyclic AMP (not shown) were completely ineffec- 
tive. ITP and GTP which can phosphorylate the 
enzyme and catalyze Ca*+-uptake gave a slight protec- 
tion at mM levels and acetyl phosphate was com- 
pletely ineffective. The results suggest hat 5’-ADP is 
the minimal structure recognized by the adenine 
nucleotide binding site which competes with FITC. 
Fig.3 demonstrates that the FITC modified Ca’+- 
ATPase cannot be phosphorylated by ATP but can be 
readily phosphorylated by Pi. Since it is assumed that 
a common aspartyl residue is phosphorylated by both 
ATP and phosphate it can be concluded that the phos- 
phorylation site is unaffected by FITC. The conclu- 
sion is in line with our finding that FITC binds to the 
45 000 Mr tryptic fragment of the Ca’+-ATPase 
whereas the phosphorylation site was identified on 
the 55 OOOM, tryptic fragment 121. 
Fig.4 demonstrates that Ca’+-uptake in FITC mod- 
ified sarcoplasmic reticulum vesicles with acetyl phos- 
phate (B) as substrate is only partly inhibited even 
though the Ca”-uptake catalysed by ATP is com- 
pletely inhibited (A). The FITC modification increased 
the initial lag in Ca2+-uptake from 30 s to 2 min and 
inhibited the steady state rate of Ca2+-uptake by 
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Fig.4. The effect of FITC on Ca*+-uptake with ATP and ace- 
tyl phosphate. SRV (2 mg/ml) was incubated for 10 min with 
or without 20 MM FITC at pH 9.0 and the reaction was termi- 
nated by removing the unreacted FITC on Sephadex G-50 
columns. Caz+uptake was assayed in the presence of 5 mM 
ATP or 10 mM acetyl phosphate and the protein concentra- 
tions in the assay mixtures were 32 ng/ml with ATP and 
160 pg/ml with acetyl phosphate. Other conditions were as in 
section 2. 
-50%. This initial lag probably reflects the very slow 
rate of phosphorylation by acetylphosphate that 
becomes the rate limiting step in Ca*+-uptake [9]. 
Similar partial inhibitions of Ca*+-uptake by FITC 
were obtained with other substrates such as carbamyl 
phosphate (65%) and with p-nitrophenylphosphate 
but with ITP an almost complete inhibition was 
obtained (not shown). These results strongly indicate 
that FITC modifies specifically the ATP binding site 
of the Ca*‘-ATPase. 
4. Discussion 
These results strongly suggest hat FITC competes 
with ATP for a common binding site and it points to 
a structural similarity between fluorescein 5-isothio- 
cyanate and ATP. The possibility that the apparent 
competition between ATP and FITC is a result of 
cooperative interactions between two different sites 
seems very unlikely because FITC inhibits also the 
binding of ATP to the enzyme (U. P., unpublished). It 
was also demonstrated that protection against FITC is 
very specific for 5’-adenine nucleotides (fig.2). 
The observations that FITC inhibits also the mam- 
malian Naf, K’-ATPase [ I] and the chloroplast proton 
ATPase (unpublished) and that ATP protects these 3 
enzymes against the inhibition points to a conserva- 
tive structure of ATP binding sites in widely different 
ion-transporting ATPase and to the presence of an 
essential ysine group involved in ATP binding. 
The location of the phosphorylation site on the 
55 000 Mr tryptic fragment of the Ca*+-ATPase [lo] 
is different from the FITC binding site which was 
identified in the 45 000 M, tryptic fragment [2]. This 
observation may suggest hat the catalytic site is made 
up of peptide segments from both the 55 000 and 
45 000 M, tryptic fragments of the enzyme or alter- 
natively, that there are two physically different ATP 
binding sites as will be discussed below. The large 
changes in the fluorescence yield of the bound chro- 
mophore in response to Ca*+-binding and to phospho- 
rylation [2,3] indicate that the microenvironment of 
the chromophore is very sensitive to changes in the 
conformation of the enzyme. This makes FITC a very 
useful tool to follow conformational changes in the 
Ca*+-ATPase from sarcoplasmic reticulum. 
Evidence for the existence of more than one type 
of ATP binding site in the Ca2+-ATPase from sarco- 
plasmic reticulum was presented before based on 
kinetic measurements [1 1 - 141. 
A low affinity ATP binding site (Km 30-500 PM) 
was identified which presumably regulates the Ca*+- 
dependent conformational transition in the dephos- 
phorylated enzyme and differs from the high affinity 
phosphorylation site. Our results indicate that the 
properties of the ATP binding sites involved in pro- 
tection against FITC resemble in many respects the 
low affinity regulatory sites: 
(1) 
(2) 
In specificity: it was demonstrated that substrates 
like ITP, GTP and acetyl phosphate which phos- 
phorylate the enzyme at mM levels were not 
effective in protection against FITC. Similarly, 
AMP P(NH)P which has a iow affinity for the 
phosphorylation site (Ki 90 PM) compared to 
ATP (Km 3 PM) but has a similar affinity as ATP 
for the regulatory site [ 131 is also as effective as 
ATP in protection against FITC inhibition (fig.2). 
The apparent low affinity for ATP for protection 
is at least an order of magnitude higher than the 
Km for phosphorylation. Since the apparent affin- 
ity for ATP protection may give an overestima- 
tion because of the competition with an irrevers- 
ible inhibitor we have also measured the initial 
rates of inactivation by different FITC concentra- 
tions in the presence of several concentrations of 
ATP and from the plot of l/v (V = the initial rate 
of inactivation) vs FITC concentration obtained 
a binding constant of 25 PM for ATP which is 
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much higher than the affinity of the phosphoryla- 
tion site for ATP (not shown). Since FITC inhib- 
its all the interactions of the enzyme with ATP at 
the phosphorylation sites (fig.3) the question 
arises what are the interrelations between the two 
ATP binding sites. The two different affinities for 
ATP may represent a single site at two different 
conformations of the enzyme - in absence of 
Ca2+ the enzyme may exist in a conformation 
which binds ATP with a low affinity but in the 
presence of Ca2+ which induces a conformational 
change the site may be converted to the high 
affinity binding site. In other words, ATP which 
binds to the enzyme in the absence of Ca2+ would 
become the phosphorylating substrate. 
This interpretation is consistent with random binding 
of ATP and Ca2+ to the enzyme which was suggested 
in [ 1.51. The other alternative is that the two sites are 
physically different sites and affect each other by 
cooperative interactions. Our recent observation that 
the affinity for AMP-P(NH)P in protection against 
FITC is higher in the presence of Ca2+ (unpublished) 
is in line with the former interpretation. 
5. Conclusions 
6) 
(ii) 
FITC inhibits the Ca’+-ATPase from sarcoplasmic 
reticulum by specifically modifying the ATP 
binding site. 
That the fluorescein-labeled enzyme can take up 
Ca2+ from the medium with acetyl phosphate as a 
substrate demonstrates that the enzyme can per- 
form the complete turnover in the absence of 
ATP. 
(iii) The low affinity and high specificity for adenine 
nucleotides in protection against FITC imply 
that the regulatory ATP binding sites are involved 
in the protection and it suggests a close interrela- 
tion or identity of the phosphorylation and the 
regulatory ATP binding sites. 
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